Zafeiri Eleftheria, Dedes Vasileios, Tzirogiannis Kostantinos, Kandylaki Agapi, Polikandrioti Maria, Panidis Dimitris, Panoutsopoulos Georgios I
Department of Nursing, University of Peloponnese.
Department of Social Work, Democritus University of Thrace.
Health Psychol Res. 2022 May 27;10(3):35644. doi: 10.52965/001c.35644. eCollection 2022.
Biofeedback is a non-invasive therapeutic method used independently or as an adjunct alongside other methods.
This study evaluated the efficacy of biofeedback in the treatment of anxiety disorders.
The sample consisted of 85 individuals with anxiety symptoms who underwent neuro-biofeedback therapy using Brain Boy Universal Professional. Anxiety was assessed by both the Hamilton Rating Scale for Anxiety (HAM-A) and Zung Anxiety Self-Assessment Scale (SAS) before the initiation and after completing ten sessions with biofeedback.
Before biofeedback and based on the HAM-A scale, 27.0% of the individuals showed mild to moderate anxiety, 16.5% medium anxiety, and 56.5% severe anxiety. After the completion of biofeedback, 90.6% of the individuals experienced mild to moderate anxiety, 5.9% medium anxiety, and 3.5% severe anxiety. Based on the SAS scale, before biofeedback, 42.4% of the individuals showed minimal to moderate anxiety, 21.2% marked severe anxiety and 36.5% most extreme anxiety. After the biofeedback, 68.2% of the individuals were within a normal range, 27.1% had minimal to moderate anxiety, 4.7% marked severe anxiety, and none in most extreme anxiety.
Both HAMA-A and SAS scales showed statistically reduced anxiety levels after biofeedback therapy. Thus, the primary symptom of anxiety can be addressed by the biofeedback method.
生物反馈是一种非侵入性治疗方法,可单独使用或与其他方法一起作为辅助手段。
本研究评估了生物反馈治疗焦虑症的疗效。
样本包括85名有焦虑症状的个体,他们使用Brain Boy Universal Professional接受了神经生物反馈治疗。在开始生物反馈治疗前以及完成十次治疗后,通过汉密尔顿焦虑量表(HAM-A)和zung焦虑自评量表(SAS)对焦虑进行评估。
在生物反馈治疗前,根据HAM-A量表,27.0%的个体表现为轻度至中度焦虑,16.5%为中度焦虑,56.5%为重度焦虑。生物反馈治疗完成后,90.6%的个体经历轻度至中度焦虑,5.9%为中度焦虑,3.5%为重度焦虑。根据SAS量表,在生物反馈治疗前,42.4%的个体表现为轻度至中度焦虑,21.2%为明显重度焦虑,36.5%为极度焦虑。生物反馈治疗后,68.2%的个体处于正常范围,27.1%有轻度至中度焦虑,4.7%为明显重度焦虑,无人处于极度焦虑状态。
HAM-A和SAS量表均显示生物反馈治疗后焦虑水平在统计学上有所降低。因此,生物反馈方法可解决焦虑的主要症状。